Thank you for your interest in participating in the 2024 STI Prevention Conference. The Scientific Program Committee invites abstracts of high quality in the areas of STI prevention research, program, policy, diagnosis, and treatment. Abstract submissions are peer-reviewed for scientific content, logical presentation, timeliness, and current interest of the topic to the scientific and STI Prevention community.

Submission of an abstract implies the commitment that the presenting author registers for the 2024 STI Prevention Conference and has adequate financial resources to attend the conference.

Submit your abstract

DEADLINE FOR LATE-BREAKER ABSTRACT SUBMISSION IS FRIDAY, JUNE 21, 2024, 11:59PM, PST.

Abstracts must be submitted electronically through the abstract submission portal. Abstracts sent by mail, fax or email will NOT be accepted. Abstracts and any amendments to submitted abstracts will not be accepted after the submission deadline. No extensions will be given.

Submitted abstracts must:

  • Reflect work where data collection ended in 2023 or 2024. This information must be included in the abstract methods section to be considered for presentation.
  • Not have been published in a peer reviewed journal prior to June 21, 2024.

Abstracts previously presented at meetings will not be accepted unless there is a substantial update of data. Multiple abstracts reporting results from the same study and overlapping abstracts from the same group of investigators are strongly discouraged.

General Abstract Format

  • Abstracts (300 words in length) should contain the following four components: 1) Background: a concise statement of the issue under investigation or a hypothesis; 2) Methods: the methods used (including the statistical analyses employed); 3) Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable; no figures or tables); and 4) Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).
  • Submitters will be asked several questions about their abstract that will enable the Scientific Committee to ensure it is reviewed appropriately. The questions pertain to topics such as the primary population of focus, gender, age group, geographic area of study, setting, disease/infection, methodology, and analytic approach.  Carefully read through the entire Abstract Classification list before submitting your abstract to ensure that your submission is read by the appropriate review team.
  • Do not include grant acknowledgements, literature references, or copyright or trademark symbols.

 

NEED HELP WRITING AN ABSTRACT?

For your reference, we have provided guidance on How to Write an Abstract with tips, advice, and how to avoid common mistakes and errors.

 

ABSTRACTS ARE CONSIDERED OFFICIAL COMMUNICATIONS TO THE CONFERENCE WITH THE FOLLOWING AGREEMENTS:

  1. Individuals submitting abstracts that are accepted agree to attend the meeting and present their abstract as scheduled (as an oral abstract, poster, and/or poster discussion presentations, as determined by the Scientific Program Committee). Once an abstract has been accepted and scheduled, it cannot be withdrawn.
  2. The presenting author will be required to register for the Conference by September 2, 2024, after having received their notification of acceptance, to attend the conference and present the abstract. If a presenting author is not registered by the above date, the Scientific Committee will remove the abstract from the program unless a co-author who will be attending the conference can present on behalf of presenting author.
  3. DISCLOSURE OF INTEREST: The STI Prevention Conference recognizes the considerable contribution that industry partners make for professional and research activities. We also recognize the need for transparency and the disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations. If your abstract is accepted, you will be requested to include a disclosure of interest statement in your oral or poster presentation.
  4. By submitting an abstract, all authors agree to release the license to the conference organizers and give permission to publish the abstract in a journal and on the website (and by doing so, certify that the abstract is original work). The presenting author is required to ensure that all co-authors are aware of the content of the abstracts before submission.

 

WHEN WILL LATE-BREAKER ACCEPTANCE NOTIFICATIONS BE SENT?

Late-breaker abstracts selected by the Scientific Program Committee for presentation at the conference will be notified by email beginning July 2024. Acceptance notifications will be sent to the presenting author. Abstracts submitted in the general call for abstracts from December 15, 2023 to March 29, 2024 will be notified by email beginning June 2024.

 

ARE SCHOLARSHIPS AVAILABLE FOR LATE-BREAKER ABSTRACT AUTHORS?

The conference is unable to provide any scholarships. If an abstract is accepted for presentation, the presenting author will be required to have the adequate financial resources to attend the conference (including conference registration) and should not submit an abstract if this is not possible.

 

STILL HAVE QUESTIONS?

Contact the 2024 STI Prevention Conference Planning Committee at conference@ashasexualhealth.org.